MOUNT LAUREL, NJ – September 29, 2017, – RhythMedix, today announced it has earned The Joint Commission’s Gold Seal of Approval® for Ambulatory Health Care Accreditation for the RhythMedix Cardiac Monitoring Center. The rigorous accreditation process symbolizes RhythMedix’s deep commitment to providing safe and effective patient ca...
Read More
The RhythmStar Remote Cardiac Monitoring System functions in three monitoring modes, Holter, which records a patient’s heart rhythm for one to two days; Event, worn for 30 days by patients who have infrequent cases of arrhythmia; and Mobile Cardiac Telemetry (MCT), which provides real-time monitoring and analysis by a registered nurse.
Read More
RhythMedix today announced that over 23,000 patients at sites across the U.S. have used the RhythmStar System after market entry in March 2015. To support commercialization, the company has undergone a rigorous non-infringement patent assessment process and secured a multi-million-dollar litigation patent defense insurance policy from Intellectual ...
Read More
Our experienced, U.S.-based experts are available to answer any questions you may have regarding your monitoring service.
Do you have a general business inquiry about RhythMedix?